Universität Wien
Achtung! Das Lehrangebot ist noch nicht vollständig und wird bis Semesterbeginn laufend ergänzt.

323005 VU Preclinical Drug Development - MPS4 (2017W)

7.00 ECTS (3.00 SWS), SPL 32 - Pharmazie
Prüfungsimmanente Lehrveranstaltung

Details

Sprache: Englisch

Lehrende

Termine

Date Time Topic
09.01.2018 14:00 - 17:00 Synthetic Methods for Med Chem
10.01.2018 14:00 - 17:00 Preclinical profiling
11.01.2018 14:00 - 17:00 ADMET basic principles
16.01.2018 14:00 - 17:00 Synth Meth Med Chem (stud pres I)
17.01.2018 14:00 - 17:00 Preclinical profiling (stud pres I)
18.01.2018 14:00 - 17:00 ADMET (stud pres I)
23.01.2018 14:00 - 17:00 Preclinical profiling (stud pres II)
24.01.2018 14:00 - 17:00 ADMET (stud pres II)
25.01.2018 14:00 - 17:00 Synth Meth Med Chem (stud pres II)
30.01.2018 14:00 - 15:30 Written evaluation


Information

Ziele, Inhalte und Methode der Lehrveranstaltung

The students should acquire basic knowledge in principles of drug synthesis, ADMET concepts and preclinical profiling.

Art der Leistungskontrolle und erlaubte Hilfsmittel

Students presentations on a given topic;
Active participation in the discussion and questions session;
Written final exam.

Mindestanforderungen und Beurteilungsmaßstab

Students should be able to understand and comprehensively and critically present original papers / projects /ideas to course topics as well as answer related questions.
Grades for the module will be deduced to 40% from the result in the written exam, to 30% from the oral presentations and 30 % from the active participation in the discussions during the course

Prüfungsstoff

Introduction lectures, recommended text book chapters, provided scientific articles (papers and reviews), as well as students presentations

Literatur

The Art of Drug Synthesis; Johnson, D. S.; Li, J. J., Eds.; John Wiley and Sons: Hoboken, 2007.
Scientific articles – material provided during the lectures.

Zuordnung im Vorlesungsverzeichnis

Letzte Änderung: Fr 31.08.2018 08:43